youtube_live
Q2 2027 earnings • in 4 days
See detailschevron_right
JHX:NYSE
James Hardie Industries PLC
$27.24
arrow_upward
+1.13%(+0.31) 1D
$27.24
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 30, 3:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for JHX...
Open
$27.14
High
$27.32
Low
$26.84
Mkt. cap
15.84B
Avg. vol.
10.70M
Volume
7.34M
P/E ratio
109.49
52-wk high
$31.43
52-wk low
$16.46
EPS
$0.25
Shares outstanding
580.52M
No. of employees
8K
Open
$27.14
High
$27.32
Low
$26.84
Mkt. cap
15.84B
Avg. vol.
10.70M
Volume
7.34M
P/E ratio
109.49
52-wk high
$31.43
52-wk low
$16.46
EPS
$0.25
Shares outstanding
580.52M
No. of employees
8K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
This Dividend Stock Yielding Quadruple the S&P 500 Looks Like a Buy Right Now
AOL.com
·
2 hours ago
The S&P 500 Is Chasing a Milestone That's Only Been Hit 9 Times Since 1926. Here’s What History Says Comes Next.
BigGo Finance
·
1 hour ago
Nasdaq's 5.3% October Slide Sets Up a Familiar Bet: History Points to a 24% Rebound
Reuters
·
2 days ago
Dow, S&P pause near records
Profile
James Hardie Industries plc is an American-Irish global building materials company and the largest global manufacturer of fibre cement products. Headquartered in Ireland, it is cross-listed on the Australian and New York Stock Exchanges. Its management team currently sits in Chicago, Illinois, United States. James Hardie was plagued by several asbestos-related scandals in the 20th century. Wikipedia
About James Hardie Industries PLC
CEOAaron Erter
Employees7.5K
Founded1888
HeadquartersDublin, Leinster, Ireland
SectorBuilding material
Websiteir.jameshardie.com.au
Analyst ratings
Based on 10 analysts giving stock ratings to JHX in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for JHX in the last 3 months.
Highest
Current $27.24
$36.00 (+32.16%)
Average
$33.65 (+23.53%)
Lowest
$30.22 (+10.96%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Rafe Jadrosich Bank of America Securities | Buy | Reiterated | $31.00 | +13.8% | 10/21/2026 |
Timothy Wojs Robert W. Baird | Buy | Maintained | $32.00 | +17.5% | 10/13/2026 |
Michael Rehaut Melius Research | Buy | Initiated | $36.00 | +32.2% | 10/06/2026 |
Unknown Analyst Melius Research | Buy | Initiated | $36.00 | +32.2% | 10/06/2026 |
Ryan Merkel William Blair | Buy | Maintained | - | - | 09/16/2026 |
Philip Ng Jefferies | Buy | Maintained | $35.00 | +28.5% | 09/16/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $35.00 | +28.5% | 09/16/2026 |
Tyler Batory Oppenheimer | Buy | Reiterated | $36.00 | +32.2% | 09/16/2026 |
Keith Hughes Truist Financial | Buy | Maintained | - | - | 09/16/2026 |
Matthew Bouley Barclays | Buy | Maintained | $35.00 | +28.5% | 09/16/2026 |
Matt McKellar RBC Capital | Hold | Reiterated | A$43.00 | +57.9% | 09/11/2026 |
Trey Grooms Stephens | Buy | Reiterated | $34.00 | +24.8% | 08/07/2026 |
Shaurya Visen Bank of America Securities | Buy | Maintained | - | - | 07/23/2026 |
Unknown Analyst Oppenheimer | Buy | Maintained | $30.00 | +10.1% | 07/16/2026 |
Joseph Michael Morgan Stanley | Buy | Maintained | $38.00 | +39.5% | 05/24/2026 |
Unknown Analyst Morgan Stanley | Buy | Maintained | $44.00 | +61.5% | 02/15/2026 |
Next call in 4 days
Fri, Nov 6, 12:00 AM
Fiscal period
Q2 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.37
Revenue / Est. (USD)
- / 1.46B
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.29B | 1.24B | 1.40B | 1.47B |
Cost of goods sold | 871.10M | 791.60M | 832.60M | 925.90M |
Cost of revenue | 871.10M | 791.60M | 832.60M | 925.90M |
Research and development expenses | 15.80M | 16.60M | 16.20M | 15.40M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 250.80M | 249.70M | 289.80M | 295.40M |
Operating expense | 266.60M | 266.30M | 306.00M | 310.80M |
Total operating expenses | 1.14B | 1.06B | 1.14B | 1.24B |
Operating income | 154.50M | 181.90M | 265.30M | 237.90M |
Other non operating income | 1.20M | -300.00K | -50.70M | 2.70M |
EBT including unusual items | -40.00M | 110.60M | 46.40M | 157.30M |
EBT excluding unusual items | 90.30M | 116.00M | 152.30M | 179.10M |
Income tax expense | 15.80M | 41.90M | 17.90M | 53.00M |
Effective tax rate | -39.50% | 37.88% | 38.58% | 33.69% |
Other operating expenses | - | - | - | - |
Net income | -55.80M | 68.70M | 28.50M | 104.30M |
Net profit margin | -4.32% | 5.54% | 2.03% | 7.07% |
Earnings per share | 0.26 | 0.24 | 0.30 | 0.36 |
Interest and investment income | 2.40M | 2.40M | 2.70M | - |
Interest expense | -67.80M | -68.00M | -65.00M | -61.50M |
Net interest expenses | -65.40M | -65.60M | -62.30M | -61.50M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 280.90M | 329.50M | 428.30M | 406.70M |
Gain or loss from assets sale | - | -26.20M | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events